Hood River Capital Management LLC Buys Sage Therapeutics Inc, Merit Medical Systems Inc, Zumiez Inc, Sells NuVasive Inc, Ligand Pharmaceuticals Inc, PRA Health Sciences Inc

• New Purchases: MMSI, ZUMZ, COHR, MLHR, LRN, DY, IPHI, GLUU, RUN, CDNA, CARB, ACIA, EVRI, MCFT, TSC, KTOS, WATT, LEVI, QTRX, AMD, ACDVF, EA, ANET, VSLR,
• Added Positions: SAGE, TELL, MGNX, MED, WIRE, LHCG, ATRC, GTLS, TRHC, LITE, SEM, VNDA, RCII, HNGR, CNMD, OFIX, CRL, AMRN, GLOB, LOPE, XPER, WMGI, MFGP,
• Reduced Positions: EEFT, ERI, MTZ, CYBR, AAWW, KNX, AMRS, MBUU, HXL, AGS, VICR, NGHC, TNDM, SRI, IIPR, BEAT, WAL, TPIC, TIER, LOVE, FCFS, HSC, WCG, FIVN, CHGG, LLNW, CSGP, ACIW, LAUR, RPD, ASGN, IART, TDOC, DMRC, EVBG, PGTI, KFY, PCTY, EXLS, PENN, COHU, BAND, PWR, GPRO, VIVE, SGMS, AGIO, ODFL, RARE,
• Sold Out: NUVA, LGND, PRAH, MXL, IDTI, TBI, WBS, VCRA, CRZO, URBN, ENS, DXPE, WPRT, VRNS, PATK, WIFI, WTFC, JEC, FRGI, RESN,

For the details of Hood River Capital Management LLC's stock buys and sells, go to https://www.gurufocus.com/guru/hood+river+capital+management+llc/current-portfolio/portfolio

1. BioTelemetry Inc (BEAT) - 954,906 shares, 3.03% of the total portfolio. Shares reduced by 3.65%
2. Eldorado Resorts Inc (ERI) - 1,276,219 shares, 3.02% of the total portfolio. Shares reduced by 25.94%
3. Sage Therapeutics Inc (SAGE) - 350,368 shares, 2.82% of the total portfolio. Shares added by 147.74%
4. Chart Industries Inc (GTLS) - 528,457 shares, 2.42% of the total portfolio. Shares added by 20.43%
5. Charles River Laboratories International Inc (CRL) - 326,175 shares, 2.40% of the total portfolio. Shares added by 4.57%

Hood River Capital Management LLC initiated holding in Merit Medical Systems Inc. The purchase prices were between $50.86 and $61.83, with an estimated average price of $56.71. The stock is now traded at around $56.30. The impact to a portfolio due to this purchase was 1.21%. The holding were 386,661 shares as of .

Hood River Capital Management LLC initiated holding in Zumiez Inc. The purchase prices were between $19.17 and $25.79, with an estimated average price of $23.65. The stock is now traded at around $22.74. The impact to a portfolio due to this purchase was 1.17%. The holding were 928,207 shares as of .

Hood River Capital Management LLC initiated holding in Coherent Inc. The purchase prices were between $97.9 and $143.26, with an estimated average price of $126.2. The stock is now traded at around $130.92. The impact to a portfolio due to this purchase was 0.89%. The holding were 124,034 shares as of .

Hood River Capital Management LLC initiated holding in Herman Miller Inc. The purchase prices were between $30.21 and $37.25, with an estimated average price of $34.82. The stock is now traded at around $37.66. The impact to a portfolio due to this purchase was 0.8%. The holding were 448,439 shares as of .

Hood River Capital Management LLC initiated holding in K12 Inc. The purchase prices were between $23.93 and $34.13, with an estimated average price of $30.35. The stock is now traded at around $31.67. The impact to a portfolio due to this purchase was 0.77%. The holding were 442,900 shares as of .

Hood River Capital Management LLC initiated holding in Dycom Industries Inc. The purchase prices were between $43.33 and $63.67, with an estimated average price of $54.94. The stock is now traded at around $46.76. The impact to a portfolio due to this purchase was 0.76%. The holding were 327,700 shares as of .

Hood River Capital Management LLC added to a holding in Sage Therapeutics Inc by 147.74%. The purchase prices were between $89.33 and $163.65, with an estimated average price of $144.22. The stock is now traded at around $166.09. The impact to a portfolio due to this purchase was 1.68%. The holding were 350,368 shares as of .

Hood River Capital Management LLC added to a holding in Tellurian Inc by 273.11%. The purchase prices were between $6.95 and $11.24, with an estimated average price of $9.36. The stock is now traded at around $8.80. The impact to a portfolio due to this purchase was 0.74%. The holding were 1,772,717 shares as of .

Hood River Capital Management LLC added to a holding in Macrogenics Inc by 112.69%. The purchase prices were between $11.11 and $25.6, with an estimated average price of $17.21. The stock is now traded at around $16.53. The impact to a portfolio due to this purchase was 0.69%. The holding were 1,443,196 shares as of .

Hood River Capital Management LLC added to a holding in Medifast Inc by 86.63%. The purchase prices were between $107.24 and $136.31, with an estimated average price of $126.83. The stock is now traded at around $138.86. The impact to a portfolio due to this purchase was 0.62%. The holding were 205,206 shares as of .

Hood River Capital Management LLC added to a holding in Encore Wire Corp by 136.73%. The purchase prices were between $49.19 and $60.35, with an estimated average price of $55.35. The stock is now traded at around $54.55. The impact to a portfolio due to this purchase was 0.55%. The holding were 332,089 shares as of .

Hood River Capital Management LLC added to a holding in LHC Group Inc by 41.16%. The purchase prices were between $88.98 and $113.79, with an estimated average price of $106.55. The stock is now traded at around $115.35. The impact to a portfolio due to this purchase was 0.48%. The holding were 290,356 shares as of .

Hood River Capital Management LLC sold out a holding in NuVasive Inc. The sale prices were between $44.53 and $58.9, with an estimated average price of $53.1.

Hood River Capital Management LLC sold out a holding in Ligand Pharmaceuticals Inc. The sale prices were between $105.93 and $142.47, with an estimated average price of $121.61.

Hood River Capital Management LLC sold out a holding in PRA Health Sciences Inc. The sale prices were between $84.93 and $114.21, with an estimated average price of $104.42.

Hood River Capital Management LLC sold out a holding in MaxLinear Inc. The sale prices were between $16.69 and $25.81, with an estimated average price of $21.76.

Hood River Capital Management LLC sold out a holding in Integrated Device Technology Inc. The sale prices were between $47.79 and $48.99, with an estimated average price of $48.43.

Hood River Capital Management LLC sold out a holding in TrueBlue Inc. The sale prices were between $21.56 and $24.79, with an estimated average price of $23.35.